|
Market Closed -
Bombay S.E.
10:02:31 13/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1,377.00 INR | -0.65% |
|
+0.42% | +8.34% |
| 11-11 | Aspen Pharmacare wins approval for generic semaglutide in Brazil, South Africa | RE |
| 11-10 | Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading | MT |
| Market Cap | 1,147B 12.17B 11.04B 10.2B 9.22B 17.36B 17.98B 122B 48.6B 613B 45.69B 44.71B 1,944B | P/E 2027 * |
31.3x | P/E 2028 * | 23.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1,117B 11.85B 10.75B 9.93B 8.97B 16.9B 17.5B 119B 47.32B 597B 44.48B 43.53B 1,893B | EV / Sales 2027 * |
3.18x | EV / Sales 2028 * | 2.79x |
| Free-Float |
68.54% | Yield 2027 * |
0.54% | Yield 2028 * | 0.61% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| DRREDDY | Delayed | |
NSE India S.E.
| DRREDDY | Delayed | |
|
NSE India S.E.
| DRREDDY | End-of-day quote |
Last Transcript: Dr. Reddy's Laboratories Limited
| 1 day | -0.65% | ||
| 1 week | +0.42% | ||
| Current month | +1.98% | ||
| 1 month | +13.42% | ||
| 3 months | +14.56% | ||
| 6 months | +5.70% | ||
| Current year | +8.34% |
| 1 week | 1,369.2 |  | 1,403.9 |
| 1 month | 1,213.05 | | 1,403.9 |
| Current year | 1,080.05 | | 1,414.4 |
| 1 year | 1,080.05 | | 1,414.4 |
| 3 years | 1,025.9 | | 1,420.2 |
| 5 years | 731 | | 1,420.2 |
| 10 years | 377.6 | | 1,420.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 59 | 30/06/2019 |
| Director of Finance/CFO | - | 31/07/2024 | |
Sanjay Sharma
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 12/05/2014 | |
Gunupati Prasad
CHM | Chairman | 65 | 01/04/2013 |
Leo Puri
BRD | Director/Board Member | 65 | 24/10/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/04/26 | Other | Global Head of Quality and PV | 35,600 | 0.0043% | - | |
| 18/12/25 | Other | Chairman | 85,738,125 | 10.2732% | ||
| 18/12/25 | Other | Director | 12,717,090 | 1.5238% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.65% | +0.42% | +10.61% | +27.04% | 12.17B | |
| +1.26% | +6.61% | +40.79% | +136.32% | 1,286B | |
| +0.79% | +3.45% | +45.84% | +93.52% | 688B | |
| +0.20% | +1.28% | +26.97% | +113.70% | 521B | |
| -0.44% | +3.69% | +41.45% | +68.91% | 386B | |
| +0.55% | +0.70% | +59.02% | +44.62% | 364B | |
| -0.12% | +0.74% | +28.39% | +58.54% | 302B | |
| +0.37% | +0.37% | +3.33% | +37.27% | 287B | |
| -0.30% | +1.14% | +38.29% | +72.46% | 252B | |
| +0.08% | +0.71% | +34.44% | +124.95% | 208B | |
| Average | +0.17% | +1.91% | +32.91% | +77.73% | 431B | |
| Weighted average by Cap. | +0.53% | +3.25% | +37.62% | +96.30% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 351B 3.73B 3.38B 3.12B 2.82B 5.32B 5.51B 37.47B 14.88B 188B 13.99B 13.69B 595B | 393B 4.17B 3.78B 3.5B 3.16B 5.95B 6.16B 41.94B 16.66B 210B 15.66B 15.32B 666B |
| Net income | 36.5B 387M 351M 325M 293M 552M 572M 3.89B 1.55B 19.51B 1.45B 1.42B 61.85B | 49.21B 522M 474M 438M 395M 745M 771M 5.25B 2.08B 26.3B 1.96B 1.92B 83.39B |
| Net Debt | -30.34B -322M -292M -270M -244M -459M -476M -3.24B -1.29B -16.22B -1.21B -1.18B -51.42B | -49.26B -523M -474M -438M -396M -746M -772M -5.25B -2.09B -26.33B -1.96B -1.92B -83.47B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | ₹1,377.00 | -0.65% | 43,137 |
| 12/11/26 | ₹1,386.00 | +0.73% | 24,358 |
| 11/11/26 | ₹1,376.00 | -0.65% | 55,416 |
| 09/11/26 | ₹1,385.00 | +1.17% | 74,169 |
| 08/11/26 | ₹1,369.00 | -0.16% | 8,599 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- DRREDDY Stock
Select your edition
All financial news and data tailored to specific country editions
